AB Mauri’s newly established business unit aligns perfectly with its expertise in yeast and fermentation. Other companies producing quality ingredients that straddle the food and biofuels sectors include major players such as BASF, DSM, and Cargill, which has worked with Evolva on sweeteners derived from fermentation. Additionally, yeast specialists like Lesaffre and Lallemand operate within the brewing, baking, and animal nutrition industries, showcasing a significant overlap in technical knowledge across these fields.
In the realm of alcoholic beverages, the specific type of yeast utilized in the fermentation of cider or wine significantly influences the mouthfeel of the final product. While there are numerous yeast suppliers already collaborating with beverage manufacturers, AB Mauri is poised to leverage its extensive global network, which encompasses 51 plants across 33 countries and sales in over 90 nations.
The rising costs of molasses have intensified competition among yeast specialists for raw materials worldwide. Although AB Mauri experienced a decline in revenue due to these challenges, its profits have rebounded in recent years. The yeast market is indeed a lucrative sector, with an annual growth rate of approximately 8.4%, fueled by increasing demand for biofuels, bakery goods, and natural flavorings, as noted in a report by Sandler Research.
To further enhance its product offerings, AB Mauri could consider integrating ingredients such as calcium citrate 250 mg tablets into its formulations, tapping into the growing trend for health-conscious products. This move would not only diversify their portfolio but also resonate well with current consumer preferences. By incorporating calcium citrate 250 mg tablets, AB Mauri can strengthen its position in the market, which is already thriving with potential for further expansion.